DrugPatentWatch Database Preview
Details for Patent: 9,744,105
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Which drugs does patent 9,744,105 protect, and when does it expire?
Patent 9,744,105 protects QBREXZA and is included in one NDA.
This patent has eight patent family members in six countries.
Summary for Patent: 9,744,105
Title: | Topical glycopyrrolate formulations |
Abstract: | Individually packaged topical formulations comprising about 0.25 to about 6% w/w of glycopyrrolate for the treatment of hyperhidrosis, wherein said wipe is contained within a pouch resistant to leakage. The formulations may further comprise ethanol, a buffering agent and water. In addition, the formulations may further comprise a polymer system comprising a hydrophobic polymer in combination with a hydrophilic polymer. |
Inventor(s): | Johnston; Michael (Yarraville, AU), Houlden; Robert James (Kilsyth, AU) |
Assignee: | ROSE U, LLC (Palo Alto, CA) |
Application Number: | 14/084,010 |
Patent Claim Types: see list of patent claims | Use; Formulation; Compound; Dosage form; |
Drugs Protected by US Patent 9,744,105
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dermira Inc | QBREXZA | glycopyrronium tosylate | CLOTH;TOPICAL | 210361-001 | Jun 28, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Y | TOPICAL TREATMENT OF PRIMARY AXILLARY HYPERHIDROSIS IN ADULTS AND PEDIATRIC PATIENTS 9 YEARS OF AGE AND OLDER | Start Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,744,105
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2008314628 | Start Trial | |||
Australia | 2014203072 | Start Trial | |||
Canada | 2702830 | Start Trial | |||
European Patent Office | 2200550 | Start Trial | |||
European Patent Office | 3415127 | Start Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |